1. Home
  2. MBINM vs VCEL Comparison

MBINM vs VCEL Comparison

Compare MBINM & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MBINM

Merchants Bancorp

N/A

Current Price

$25.31

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$33.52

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBINM
VCEL
Founded
N/A
1989
Country
United States
United States
Employees
735
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
1.7B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
MBINM
VCEL
Price
$25.31
$33.52
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$57.75
AVG Volume (30 Days)
18.2K
644.9K
Earning Date
N/A
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
60.00
EPS
N/A
0.32
Revenue
N/A
$276,259,000.00
Revenue This Year
N/A
$19.10
Revenue Next Year
N/A
$17.95
P/E Ratio
N/A
$111.97
Revenue Growth
N/A
16.45
52 Week Low
$24.00
$28.95
52 Week High
$25.96
$45.97

Technical Indicators

Market Signals
Indicator
MBINM
VCEL
Relative Strength Index (RSI) 54.81 48.78
Support Level $25.04 $31.24
Resistance Level $25.43 $34.77
Average True Range (ATR) 0.21 1.46
MACD 0.04 0.24
Stochastic Oscillator 87.42 49.86

Price Performance

Historical Comparison
MBINM
VCEL

About MBINM Merchants Bancorp

Merchants Bancorp is a United States-based bank holding company operating multiple lines of business focused on FHA multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. Its segments include Multi-family Mortgage Banking, which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing, which offers mortgage warehouse financing, commercial loans and deposit services; and the Banking segment, which generates maximum revenue and provides portfolio lending for multi-family and healthcare facility loans, residential mortgage banking, agricultural lending, SBA lending and community banking.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: